Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study

Abstract

Background: Long-term corticosteroid (CS) use is associated with increased mortality in patients with asthma, and comorbid bronchiectasis is also associated with frequent asthma exacerbation and increased healthcare use. However, there is limited information on whether bronchiectasis further increases mortality in patients with CS-dependent asthma. This study examined the impact of bronchiectasis on mortality in patients with CS-dependent asthma. Methods: A retrospective cohort of patients with CS-dependent asthma ⩾18 years old was established using records from the Korean National Health Insurance Service database from 2005 to 2015. Patients with CS-dependent asthma with and without bronchiectasis were matched by age, sex, type of insurance, and Charlson comorbidity index. We evaluated the hazard ratio (HR) for all-cause mortality in patients with bronchiectasis compared with those without bronchiectasis. Results: The study cohort included 754 patients with CS-dependent asthma with bronchiectasis and 3016 patients with CS-dependent asthma without bronchiectasis. Patients with CS-dependent asthma with bronchiectasis had a higher all-cause mortality than those without bronchiectasis (8429/100,000 versus 6962/100,000 person-years, p < 0.001). The adjusted HR for mortality in patients with CS-dependent asthma with bronchiectasis relative to those without bronchiectasis was 1.33 (95% confidence interval, 1.18–1.50), and the association was primarily significant for respiratory diseases (subdistribution HR = 1.65, 95% confidence interval, 1.42–1.92). Conclusions: Bronchiectasis further increases all-cause mortality in patients with CS-dependent asthma, a trend that was especially associated with respiratory diseases including chronic obstructive pulmonary disease. Strategies to improve treatment outcomes in patients with CS-dependent asthma with bronchiectasis are urgently needed to improve long-term survival. The reviews of this paper are available via the supplemental material section.

Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study

“…Previous research revealed that patients with COPD or asthma showed more severe clinical course and worse outcome if they have comorbid bronchiectasis. 13 In line with the study, comorbid airway disease may play a major role in poorer clinical outcomes in bronchiectasis patients with COVID-19.…”

Respiratory symptoms and health-related quality of life in post-tuberculosis subjects with physician-diagnosed bronchiectasis: a cross-sectional study

“…Many previous studies showed corticosteroid use in asthma is associated with pulmonary TB (41), which in turn, may be related to post-TB bronchiectasis. It is also well established that bronchiectasis is a common comorbidity in subjects with severe asthma (42)(43)(44). As our study is crosssectional, we could not provide the causal inferences of those conditions.…”

Coexisting Respiratory Comorbidities Increase Mortality in Patients with Asthma: National Cohort Study

“…However, the difference in mortality was not signi cant after adjusting for covariables 23 . In contrast, another study evaluated the impact of bronchiectasis on mortality in patients with severe asthma and showed that bronchiectasis was associated with all-cause mortality 24 . As the former study evaluated only in-hospital mortality, and the latter evaluated severe asthma patients, there are limited data on this issue.…”